PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Unité Des Virus Emergents (UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection), 13005, Marseille, France. franck.touret@univ-amu.fr.\', \'Unité Des Virus Emergents (UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection), 13005, Marseille, France.\', \'Aix-Marseille Univ, INSERM U1068, CNRS UMR7258, Institut Paoli-Calmettes, CRCM, Marseille, France.\', \'Institut Français de Bioinformatique (IFB), UMS 3601-CNRS, Université Paris-Saclay, Orsay, France.\', \'Aix-Marseille Univ, INSERM, Lab. Theory and Approaches of Genome Complexity (TAGC), Marseille, France.\', \'AFMB UMR 7257, Aix-Marseille Université, CNRS, Marseille, France.\', \'Unité Des Virus Emergents (UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection), 13005, Marseille, France. bruno.coutard@univ-amu.fr.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41598-020-70143-6
?:doi
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 32753646
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
is ?:relation_isRelatedTo_publication of
?:title
  • In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all